260 related articles for article (PubMed ID: 17720791)
21. CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718.
Li J; Ma M; Sarker MR; McClane BA
mBio; 2013 Oct; 4(5):e00770-13. PubMed ID: 24105766
[TBL] [Abstract][Full Text] [Related]
22. Evidence that compatibility of closely related replicons in Clostridium perfringens depends on linkage to parMRC-like partitioning systems of different subfamilies.
Watts TD; Johanesen PA; Lyras D; Rood JI; Adams V
Plasmid; 2017 May; 91():68-75. PubMed ID: 28390955
[TBL] [Abstract][Full Text] [Related]
23. Comparison of virulence plasmids among Clostridium perfringens type E isolates.
Li J; Miyamoto K; McClane BA
Infect Immun; 2007 Apr; 75(4):1811-9. PubMed ID: 17261608
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.
Fisher DJ; Fernandez-Miyakawa ME; Sayeed S; Poon R; Adams V; Rood JI; Uzal FA; McClane BA
Infect Immun; 2006 Sep; 74(9):5200-10. PubMed ID: 16926413
[TBL] [Abstract][Full Text] [Related]
25. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
[TBL] [Abstract][Full Text] [Related]
26. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.
Gonçalves LA; Lobato ZI; Silva RO; Salvarani FM; Pires PS; Assis RA; Lobato FC
Arch Microbiol; 2009 Nov; 191(11):847-51. PubMed ID: 19779698
[TBL] [Abstract][Full Text] [Related]
27. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.
Garcia JP; Adams V; Beingesser J; Hughes ML; Poon R; Lyras D; Hill A; McClane BA; Rood JI; Uzal FA
Infect Immun; 2013 Jul; 81(7):2405-14. PubMed ID: 23630957
[TBL] [Abstract][Full Text] [Related]
28. Expression and purification of functional Clostridium perfringens alpha and epsilon toxins in Escherichia coli.
Zhao Y; Kang L; Gao S; Zhou Y; Su L; Xin W; Su Y; Wang J
Protein Expr Purif; 2011 Jun; 77(2):207-13. PubMed ID: 21300155
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic resistance plasmids and mobile genetic elements of Clostridium perfringens.
Adams V; Han X; Lyras D; Rood JI
Plasmid; 2018 Sep; 99():32-39. PubMed ID: 30055188
[TBL] [Abstract][Full Text] [Related]
30. Detection of beta2 and major toxin genes by PCR in Clostridium perfringens field isolates of domestic animals suffering from enteritis or enterotoxaemia.
Sting R
Berl Munch Tierarztl Wochenschr; 2009; 122(9-10):341-7. PubMed ID: 19863004
[TBL] [Abstract][Full Text] [Related]
31. Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens.
Bannam TL; Teng WL; Bulach D; Lyras D; Rood JI
J Bacteriol; 2006 Jul; 188(13):4942-51. PubMed ID: 16788202
[TBL] [Abstract][Full Text] [Related]
32. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.
Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW
Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825
[TBL] [Abstract][Full Text] [Related]
33. Identification of the channel-forming domain of Clostridium perfringens Epsilon-toxin (ETX).
Knapp O; Maier E; Benz R; Geny B; Popoff MR
Biochim Biophys Acta; 2009 Dec; 1788(12):2584-93. PubMed ID: 19835840
[TBL] [Abstract][Full Text] [Related]
34. Multiplex polymerase chain reaction assay for genotyping Clostridium perfringens.
Meer RR; Songer JG
Am J Vet Res; 1997 Jul; 58(7):702-5. PubMed ID: 9215442
[TBL] [Abstract][Full Text] [Related]
35. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells.
Shortt SJ; Titball RW; Lindsay CD
Hum Exp Toxicol; 2000 Feb; 19(2):108-16. PubMed ID: 10773840
[TBL] [Abstract][Full Text] [Related]
36. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
Li Q; Xin W; Gao S; Kang L; Wang J
Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
[TBL] [Abstract][Full Text] [Related]
37. Identification of tyrosine 71 as a critical residue for the cytotoxic activity of Clostridium perfringens epsilon toxin towards MDCK cells.
Jiang Z; Chang J; Wang F; Yu L
J Microbiol; 2015 Feb; 53(2):141-6. PubMed ID: 25626370
[TBL] [Abstract][Full Text] [Related]
38. Two novel membrane proteins, TcpD and TcpE, are essential for conjugative transfer of pCW3 in Clostridium perfringens.
Wisniewski JA; Teng WL; Bannam TL; Rood JI
J Bacteriol; 2015 Feb; 197(4):774-81. PubMed ID: 25488300
[TBL] [Abstract][Full Text] [Related]
39. Disruption of a toxin gene by introduction of a foreign gene into the chromosome of Clostridium perfringens using targetron-induced mutagenesis.
Chen Y; Caruso L; McClane B; Fisher D; Gupta P
Plasmid; 2007 Sep; 58(2):182-9. PubMed ID: 17553563
[TBL] [Abstract][Full Text] [Related]
40. Effect of Clostridium perfringens epsilon toxin on MDCK cells.
Borrmann E; Günther H; Köhler H
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):85-92. PubMed ID: 11549414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
